MIRAVANT MEDICAL TECHNOLOGIES
SC 13G/A, 1999-02-12
PHARMACEUTICAL PREPARATIONS
Previous: NEW PARADIGM SOFTWARE CORP, 10QSB, 1999-02-12
Next: BROOKS AUTOMATION INC, SC 13G/A, 1999-02-12



<PAGE>   1

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934

AMENDMENT NO:     4

Name of Issuer:   Miravant Medical Technologies, Inc. (formerly known as PDT, 
                  Inc.)

Title of Class of Securities:       Common Stock

CUSIP Number:     69329P

Name, address and telephone number of person authorized to receive Notice and
Communications: 

                           K. Leonard Judson, Esq.
                           May, Potenza, Judson & Baran, P.C.
                           201 North Central Avenue, Suite 2210
                           Phoenix, AZ  85073-0022
                           (602) 252-1110

Check the following box if a fee is being paid with this statement [ ]. (A fee
is not required only if the filing person: (1) has a previous statement on file
reporting beneficial ownership of more than five percent of the class of
securities described in Item 1; and (2) has filed no amendment subsequent
thereto reporting beneficial ownership of five percent or less of such class.)
(See Rule 13d-7.)

*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).

CUSIP No.:  69329P

Date of Event Which
Requires Filing of Statement:   Forty-five days after end of calendar year 
                               (02/14/99)

Check the appropriate box to designate the rule pursuant to which this Schedule
is filed:

         [ ]      Rule 13d-1(b)
         [x]      Rule 13d-1(c)
         [x]      Rule 13d-1(d)


1.       NAME OF REPORTING PERSON



                                  Page 1 of 4
<PAGE>   2
         S.S. OR I.R.S. IDENTIFICATION NO. OF THE ABOVE PERSON

         Paul F. Glenn, Trustee, Paul F. Glenn Revocable Trust

2.       CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP:
         (a)               [  ]
         (b)               [  ]

3.       SEC USE ONLY

4.       CITIZENSHIP OR PLACE OF ORGANIZATION

         Paul F. Glenn is a United States citizen and the Paul F. Glenn
         Revocable Trust is formed under the laws of the State of Arizona

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH:

         5.       SOLE VOTING POWER
                  10,920

         6.       SHARE VOTING POWER
                  -0-

         7.       SOLE DISPOSITIVE POWER
                  10,920

         8.       SHARED DISPOSITIVE POWER
                  -0-

9.       AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON:
         10,920

10.      CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

         [  ]

11.      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
         less than 5%

12.      TYPE OF REPORTING PERSON*
         Paul F. Glenn - IN
         Paul F. Glenn Revocable Trust - 00



                                  Page 2 of 4
<PAGE>   3
Item 1 (a)        Name of Issuer:
                  Miravant Medical Technologies, Inc. (formerly known as PDT, 
                  Inc.)

Item 1 (b)        Address of Principal Business Office, or, if none, Resident
                  7408 Hollister Avenue, Santa Barbara, CA  93117

Item 2 (a)        Name of Person Filing:
                  Paul F. Glenn, as Trustee of the Paul F. Glenn Revocable
                  Trust, an Arizona revocable trust created by Declaration of
                  Trust, dated August 23, 1990, as amended through the date
                  hereof. Mr. Glenn is the sole trustee of the Paul F. Glenn
                  Revocable Trust and has the same business address ("Reporting
                  Person")

Item 2 (b)        Address of Principal Business Office or Residence:
                  P.O. Box 50310, Santa Barbara, CA  93108

Item 2 (c)        Citizenship:
                  Reporting Person is a United States citizen

Item 2 (d)        Title of Class of Securities:
                  Common Stock

Item 2 (e)        CUSIP Number:
                  69329P

Item 3 (a)        If this statement is filed pursuant to Rule 13d-1(b), or
                  13d-2(b), check whether the person filing is a: This
                  statement is not filed pursuant to the foregoing rules.

Item 4 (a)        Amount Beneficially Owned:
                  10,920

Item 4 (b)        Percent of class:
                  less than 5%

Item 4 (c)        Number of shares as to which such person has:

                  (i)      sole power to vote or to direct the vote: 10,920

                  (ii)     shared power to vote or to direct the vote: -0-

                  (iii)    sole power to dispose or to direct the disposition
                           of: 10,920

                  (iv)     shared power to dispose or to direct the disposition
                           of: -0-


                                  Page 3 of 4
<PAGE>   4
Item 5            Ownership of Five Percent or Less of a Class:

                  This statement is being filed to report the fact that the
                  Reporting Person, during the reporting period, has ceased to
                  be the beneficial owner of more than five percent of the class
                  of securities identified herein.

Item 6            Ownership of More than Five Percent on Behalf of Another
                  Person:

                  Other than the Reporting Person, no other person has any right
                  to receive or the power to direct the receipt of dividends
                  from, or the proceed or sales of the securities identified in
                  this Schedule 13G.

Item 7            Identification and Classification of the Subsidiary which
                  Acquired the Security Being Reported on by the Parent Holding
                  Company:

                  This Schedule 13G is not being filed on behalf of a parent
                  holding company or a subsidiary.

Item 8            Identification and Classification of Members of the Group:

                  This Schedule 13G is not being filed on behalf of any group.

Item 9            Notice of Dissolution of Group:

                  No notice of dissolution of a group is reported in this
                  Schedule 13G.

Item 10           Certification

                  By signing below I certify that, to the best of my knowledge
                  and belief, the securities referred to above were acquired in
                  the ordinary course of business and were not acquired and are
                  not held for the purpose of or with the effect of changing or
                  influencing the control of the issuer of the securities and
                  were not acquired and are not held in connection with or as
                  participation in any transaction having such purposes or
                  effect.

SIGNATURE

         After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.

         Dated:   February 11, 1999

         /s/ K. Leonard Judson
         ------------------------------------------------------
         Paul F. Glenn, by K. Leonard Judson, Attorney-in
         Fact for Paul F. Glenn (Power of Attorney for execution
         by K. Leonard Judson, on behalf of Paul F. Glenn, has
         been previously filed with the United States Securities
         and Exchange Commission)


                                  Page 4 of 4


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission